title: A population of immature cerebellar parallel fibre synapses are insensitive to adenosine but are inhibited by hypoxia.
abstract: The purine adenosine plays an important role in a number of physiological and pathological processes and is neuroprotective during hypoxia and ischemia. The major effect of adenosine is to suppress network activity via the activation of A(1) receptors. Here we report that in immature cerebellar slices, the activation of A(1) receptors has variable effects on parallel fibre synaptic transmission, ranging from zero depression to an almost complete abolition of transmission. Concentration-response curves suggest that the heterogeneity of inhibition stems from differences in A(1) receptor properties which could include coupling to downstream effectors. There is less variation in the effects of adenosine at parallel fibre synapses in slices from older rats and thus adenosine signalling appears developmentally regulated. In the cerebellum, hypoxia increases the concentration of extracellular adenosine leading to the activation of A(1) receptors (at adenosine-sensitive parallel fibre synapses) and the suppression of glutamate release. It would be predicted that the synapses that were insensitive to adenosine would be less depressed by hypoxia and thus maintain function during metabolic stress. However those synapses which were insensitive to adenosine were rapidly inhibited by hypoxia via a mechanism which was not reversed by blocking A(1) receptors. Thus another mechanism must be responsible for the hypoxia-mediated depression at these synapses. These different mechanisms of depression may be important for cell survival and for maintenance of cerebellar function following oxygen starvation.
authors.affiliation: Neuroscience Group, School of Life Sciences, University of Warwick, Coventry, UK.
authors.forename: Alison
authors.initials: A
authors.lastname: Atterbury
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Wall
mesh_terms: D000241:Adenosine / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D000831:Animals, Newborn; D015687:Cell Hypoxia / Q000187:drug effects / Q000502:physiology; D002531:Cerebellum / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology*; D009924:Organ Culture Techniques; D051381:Rats; D017208:Rats, Wistar; D043682:Receptor, Adenosine A1 / Q000378:metabolism*; D013569:Synapses / Q000187:drug effects / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
chemical_list: D043682:Receptor, Adenosine A1; D000241:Adenosine